Pan Chen

667 total citations · 1 hit paper
14 papers, 350 citations indexed

About

Pan Chen is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pan Chen has authored 14 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pan Chen's work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (4 papers). Pan Chen is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (4 papers). Pan Chen collaborates with scholars based in China, Saudi Arabia and United States. Pan Chen's co-authors include Mei Yi, Bo Xiang, Zhaoyang Zeng, Wei Xiong, Guiyuan Li, Xin Lin, Hongmin Yang, Wangning Gu, Tengfei Xiao and Minghua Yang and has published in prestigious journals such as Molecular Cancer, Cancer Letters and Cell Death and Disease.

In The Last Decade

Pan Chen

12 papers receiving 349 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulatory mechanisms of PD-1/PD-L1 in cancers

2024 273 citations Xin Lin, Pan Chen et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pan Chen China	5	138	122	115	71	70	14	350
Yaqun Li China	5	182 1.3×	106 0.9×	113 1.0×	36 0.5×	58 0.8×	10	320
Christophe Van Berckelaer Belgium	11	214 1.6×	100 0.8×	86 0.7×	122 1.7×	61 0.9×	22	350
Jinen Song China	10	222 1.6×	159 1.3×	157 1.4×	92 1.3×	63 0.9×	14	439
Marie Ancion Belgium	4	128 0.9×	93 0.8×	112 1.0×	49 0.7×	41 0.6×	7	289
Hui Guan China	8	180 1.3×	112 0.9×	125 1.1×	72 1.0×	94 1.3×	26	426
Militsa Rakina Russia	8	156 1.1×	157 1.3×	235 2.0×	80 1.1×	50 0.7×	12	410
Xianjing Chu China	7	201 1.5×	127 1.0×	87 0.8×	61 0.9×	100 1.4×	12	399
Madison Canning United States	3	198 1.4×	142 1.2×	129 1.1×	89 1.3×	63 0.9×	5	372
Susanna Lauttia Finland	5	218 1.6×	152 1.2×	210 1.8×	69 1.0×	45 0.6×	6	389

Countries citing papers authored by Pan Chen

Since Specialization

Citations

This map shows the geographic impact of Pan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Chen more than expected).

Fields of papers citing papers by Pan Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Chen. The network helps show where Pan Chen may publish in the future.

Co-authorship network of co-authors of Pan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Pan Chen. A scholar is included among the top collaborators of Pan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pan Chen. Pan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Quan, Hu, et al.. (2025). Acetylated KIAA1429 by TIP60 facilitates metastasis and immune evasion of hepatocellular carcinoma via N6-methyladenosine-KDM5B-mediated regulation of FoxO1. Cell Death Discovery. 11(1). 210–210.

Zhang, Haixia, Siyang Liu, Dan Wang, et al.. (2025). Combining decitabine with radiotherapy to enhance nasopharyngeal carcinoma radiosensitivity via the TFAP2C-OTUD1-SLC25A11 axis. Cell Death and Disease. 16(1). 525–525. 2 indexed citations

Yang, Yujie, Yian Wang, Hongke Qu, et al.. (2025). CircCDYL promotes glycolysis to drive the progression of nasopharyngeal carcinoma. Journal of Advanced Research.

Fu, Yaw‐Syan, Ling Tang, Bo Song, et al.. (2025). O-GlcNAc-modified HOXA9 suppresses ferroptosis via promoting UBR5-mediated SIRT6 degradation in nasopharyngeal carcinoma. Neoplasia. 62. 101142–101142. 3 indexed citations

Liu, Feng, Ling Tang, Yanzhu Chen, et al.. (2024). Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2. Cell Death and Disease. 15(4). 279–279. 20 indexed citations

Liu, Huai, Yanxian Li, Ling Tang, et al.. (2024). UBR5 metabolically reprograms nasopharyngeal carcinoma cells to promote glycolysis and M2 polarization via SPLUNC1 signaling. npj Precision Oncology. 8(1). 252–252. 3 indexed citations

Wang, Dan, Jing He, Si‐Yang Maggie Liu, et al.. (2024). Anlotinib synergizes with venetoclax to induce mitotic catastrophe in acute myeloid leukemia. Cancer Letters. 593. 216970–216970. 2 indexed citations

Ge, Junshang, Ying Liu, Pan Chen, et al.. (2024). FOXA1 enhances antitumor immunity via repressing interferon-induced PD-L1 expression in nasopharyngeal carcinoma. Journal for ImmunoTherapy of Cancer. 12(11). e010091–e010091. 3 indexed citations

Lin, Xin, Pan Chen, Zhaoyang Zeng, et al.. (2024). Regulatory mechanisms of PD-1/PD-L1 in cancers. Molecular Cancer. 23(1). 108–108. 273 indexed citations breakdown →

10.

Wang, Dan, Hongke Qu, Jie Wu, et al.. (2024). circTP63-N suppresses the proliferation and metastasis of nasopharyngeal carcinoma via engaging with HSP90AB1 to modulate the YAP1/Hippo signaling pathway. Science China Life Sciences. 68(3). 689–705. 5 indexed citations

11.

Wang, Dan, et al.. (2023). Circadian clock protein Bmal1 accelerates acute myeloid leukemia by inhibiting ferroptosis through the EBF3/ALOX15 axis. Cancer Science. 114(8). 3446–3460. 17 indexed citations

12.

Tang, Ling, Sha Gong, Tengfei Xiao, et al.. (2023). USP7 inhibits the progression of nasopharyngeal carcinoma via promoting SPLUNC1-mediated M1 macrophage polarization through TRIM24. Cell Death and Disease. 14(12). 852–852. 18 indexed citations

13.

Tang, Ling, Ling Peng, Huai Liu, et al.. (2022). SPLUNC1 regulates LPS-induced progression of nasopharyngeal carcinoma and proliferation of myeloid-derived suppressor cells. Medical Oncology. 39(12). 214–214. 3 indexed citations

14.

Xie, Min, et al.. (2022). Homoharringtonine combined with cladribine and aclarubicin (HCA) in acute myeloid leukemia: A new regimen of conventional drugs and its mechanism. Oxidative Medicine and Cellular Longevity. 2022(1). 8212286–8212286. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact